Liddle's syndrome

American Journal of Medicine

Volumn 104, Issue 3, 1998, Pages 301-309

  Palmer, Biff F ^a   Alpern, Robert J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; SODIUM CHANNEL;

ADOLESCENT; ALDOSTERONE BLOOD LEVEL; APICAL MEMBRANE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOKALEMIC ALKALOSIS; KIDNEY COLLECTING TUBULE; LIDDLE SYNDROME; METABOLIC ALKALOSIS; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW;

EID: 0032033133     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00018-7     Document Type: Article

References (32)

1. 1. Liddle GW, Bledsoe T, Coppage WS Jr. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians. 1963;76:199-213.
2. 2. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited. A disorder of sodium reabsorption in the distal tubule. NEJM. 1994;330:178-181.
3. 3. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
4. 4. Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nature Genetics. 1995;11:76-82.
5. 5. Tamura H, Schild L, Enomoto N, et al. Liddle disease caused by a missense mutation of β subunit of the epithelial sodium channel gene. J Clin Invest. 1996;97:1780-1784.
6. 6. Young WF, Hogan MJ, Klee GG, et al. Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc. 1990;65:96-110.
7. 7. Rich GM, Ulick S, Cook S, et al. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med. 1992;116: 813-820.
8. 8. Kassirer JP, London AM, Goldman DM, Schwartz WB. On the pathogenesis of metabolic alkalosis in hyperaldosteronism. Am J Med. 1970;49:306-315.
9. 9. Nakada T, Koike H, Akiya T, et al. Liddle's syndrome, an uncommon form of hyporeninemic hypoaldosteronism: functional and histopathological studies. J Urology. 1987;137:636-640.
10. 10. Gonzalez-Campoy J, Romero J, Knox FG. Escape from the sodium-retaining effects of mineralcorticoids: role of ANF and intrarenal hormone systems. Kidney Int. 1989;35:767-777.
11. 11. Yokota N, Bruneau BG, de Bold ML, de Bold AJ. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. J Clin Invest. 1994;94:1938-1946.
12. 12. Canessa CM, Horisberger J, Rossier BC. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature. 1993; 361:467-470.
13. + channel. FEBS Lett. 1993;318: 95-99.
14. + channel is made of three homologous subunits. Nature. 1994; 367:463-467.
15. + channel. J Biolog Chem. 1996; 271:807-816.
16. + channels: insights and outlooks. News Physiol Sci. 1997;12:55-62.
17. 17. Schild L, Canessa CM, Shimkets RA, et al. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA. 1995;92:5699-5703.
18. 18. Warnock DG, Bubien JK. Liddle syndrome: clinical and cellular abnormalities. Hosp Practice. 1994;July:95-106.
19. + channels by β-subunit mutation. Am J Physiol. 1996;270:C208-213.
20. + channels in Liddle's disease. Am J Physiol. 1996;270:C214-223.
21. 21. Hansson JH, Schild L, Lu Y, et al. A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA. 1995;92: 11495-11499.
22. 22. Schild L, Lu Y, Gautschi I, et al. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J. 1996;15:2381-2387.
23. 23. Bork P, Sudol M. The WW domain: a signalling site in dystrophin? TIBS. 1994;19:531-533.
24. 24. Andre B, Springael J. WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding yes-associated protein YAP65. Biochem Biophys Res Comm. 1994;205:1201-1205.
25. 25. Chen HI, Sudol M. The WW domain of yes-associated protein binds a proline-rich ligand that differs from the consensus established for src homology 3-binding modules. Proc Natl Acad Sci USA. 1995;92:7819-7823.
26. 26. Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Comm. 1992;185:1155-1161.
27. + channel deleted in Liddle's syndrome. EMBO J. 1996;15:2371-2380.
28. 28. Zhang JZ, Davletov BA, Sudhof TC, Anderson RGW. Synaptotagmin I is a high affinity receptor for clathrin AP-2: implications for membrane recycling. Cell. 1994;78:751-760.
29. 29. Scheffner M, Huibregtse JM, Vierstra RC, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquintin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495-505.
30. 30. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA. 1995;92:2563-2567.
31. 31. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13-21.
32. + channel. Cell. 1995;83:969-978.